Why should we need the gut microbiota to respond to cancer therapies?
2014
Viaud, Sophie | Daillere, Romain | Yamazaki, Takahiro | Lepage, Patricia | Boneca, Ivo | Goldszmid, Romina | Trinchieri, Giorgio | Zitvogel, Laurence
Cyclophosphamide, one of the most efficient tumoricidal, antiangiogenic, and immunostimulatory drugs employed to date mediates part of its effects through intestinal bacteria, against which the host becomes immunized during treatment. Our recent work suggests that anti-commensal effector pT(H)17 and memory T(H)1 CD4(+) T-cell responses are indispensable for optimal anticancer effects as mediated by cyclophosphamide.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by Institut national de la recherche agronomique